Janus Henderson Group PLC Zai Lab LTD Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Zai Lab LTD stock. As of the latest transaction made, Janus Henderson Group PLC holds 6,527,567 shares of ZLAB stock, worth $143 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,527,567
Previous 4,428,011
47.42%
Holding current value
$143 Million
Previous $70.9 Million
59.47%
% of portfolio
0.06%
Previous 0.04%
Shares
18 transactions
Others Institutions Holding ZLAB
# of Institutions
117Shares Held
40.9MCall Options Held
63.1KPut Options Held
420K-
Wellington Management Group LLP Boston, MA7.12MShares$156 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA5.31MShares$116 Million0.02% of portfolio
-
Woodline Partners LP San Francisco, CA2.33MShares$51 Million0.41% of portfolio
-
Viking Global Investors LP2.04MShares$44.6 Million0.14% of portfolio
-
Bamco Inc New York, NY1.79MShares$39.2 Million0.09% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.14B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...